The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
But one of the most important things to take away from this graph is the fact that the risk estimate summarized from all the studies, what we're sort of calling the poolled one here in red, is virtually identical to the risk estimate derived solely from the 2024 alkist study, which was done in Sweden.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
Now importantly and I was a little surprised to see this this publication was not a metaanalysis.
the primary study actually focused on how acetaminophen used during pregnancy correlated with the mother's genetic predisposition for autism. and they didn't find any significant association.
So in the case of autism, there were six observational studies that met their criteria for inclusion and the authors reported that these six studies quote consistently reported a positive association between prenatal acettomenophen use and ASD autism spectrum disorder with an exposure response relationship observed in four of the five studies that evaluated the relationship.
The dose response was only present in a partially adjusted statistical model where it disappeared in what was called the fully adjusted model.